NEWS
March 19, 2012 | By Shari Roan, Los Angeles Times / For the Booster Shots blog
Diabetes affects more than 25 million Americans. New medications and strategies to treat the disease are greatly needed. But the jury is still out on the experimental medication dapagliflozin. The medication looks to have significant benefits and risks, according to a study published Monday. Dapagliflozin is being developed by Bristol-Myers-Squibb Co. in partnership with AstraZeneca. It represents a new class of diabetes medications called selective renal sodium glucose contransporter inhibitors.
HEALTH
November 7, 2011 | By Steve Dudley, Special to the Los Angeles Times
A short while ago, Lars came in for a visit. He's a friendly, happy-go-lucky guy with a desk job in some sort of marine industry. The bulk of his visits have revolved around his passion for softball. He plays on three teams year round, and from time to time his competitive edge gets the better of him and he twists an ankle or pulls a muscle and comes in to get patched up. I remind him he's 45, not 25, that it's not Game 7 of the World Series, that he should go a little easy on himself.
NEWS
May 19, 2011 | By Marissa Cevallos, HealthKey / For the Booster Shots blog
Smart phones have already supplemented the doctor’s office and personal computers as sources of health advice — and now it appears car companies are driving into the on-the-go consumer health market. Ford is developing a way to display pollen counts and other allergen levels to drivers using its existing link to smart phone apps, the car company announced Wednesday. Ford has also made a prototype to synchronize glucose monitoring devices via Bluetooth. The car displays glucose levels and sounds an alert if they fall too low. A statement from Ford explains how this technology can help diabetics and allergy sufferers: “For people with diabetes and their caregivers, constant knowledge and control of glucose levels is critical to avoiding hypoglycemia or low glucose, which can cause confusion, lightheadedness, blurry vision and a host of other symptoms that could be dangerous while driving.
SPORTS
April 15, 2011 | Bill Dwyre
Other than driving a race car 200 mph while monitoring a life-threatening illness, Charlie Kimball is a normal guy. Kimball will drive in the Toyota Grand Prix of Long Beach on Sunday. He is 26 and is two races into his rookie season on the Izod IndyCar circuit. He already has a top-10 finish, and is somebody with almost unlimited promise for a lucrative racing future on the highest level. Except for the diabetes. "It was Oct. 16, 2007," Kimball recalls. "I went to a doctor because I had a skin rash.
NEWS
February 18, 2011 | By Eryn Brown, Los Angeles Times
Yes, he's had numerous stints on reality TV and millions of records sold -- but singer Bret Michaels may be best known as the star of a real-life medical drama. In April 2010, he had an emergency appendectomy. Less than two weeks later, he had a brain hemorrhage. A month after that, he had a stroke, caused by a hole in his heart. He had surgery to repair the heart defect in January. Michaels also has Type 1 diabetes, which was diagnosed when he was 6 years old. He spoke about how he deals with that disease in a recent interview with Diabetes Health magazine.
NEWS
February 10, 2011 | Melissa Healy, Los Angeles Times
Many food activists and public health researchers are ready to pin a substantial portion of blame for the nation's obesity epidemic on the skyrocketing consumption of high-fructose corn syrup, widely used to sweeten processed foods and beverages in the U.S. since the 1980s. But food and beverage makers are fighting back . Glucose and fructose are both simple sugars--and equal parts of each is the recipe for table sugar. (High-fructose corn syrup is a bit more intensely sweet because it's made up of 55% fructose.)